Histological classification is crucial in guiding treatment for lymphoma. Different subtypes respond differently to therapies. For instance, treatment strategies for Hodgkin Lymphoma often include chemotherapy and radiation, whereas targeted therapies like rituximab are used for certain B-cell Non-Hodgkin Lymphomas.
